Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Wesley H. Uriel Cavan S. David M. Robert L. Michael Kevin Self Sandkovsky Reilly Vock Gottlieb Mack Golden D, W. Self, U. Sandkovsky, Cavan Reilly +496 more

